Pyrrole derivatives, their preparation and their therapeutic use

Details for Australian Patent Application No. 2005279086 (hide)

Owner Sanofi-Aventis

Inventors Barth, Francis; Rinaldi-Carmona, Murielle; Congy, Christian; Hortala, Laurent

Agent A J Park

Pub. Number AU-A-2005279086

PCT Pub. Number WO2006/024777

Priority 0408773 09.08.04 FR

Filing date 2 August 2005

Wipo publication date 9 March 2006

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024777 Priority application(s): WO2006/024777

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005279087-Method for preparing Naminopiperedine and its salts

2005279085-N(1 H-indolyl)-1 H-indole-2-carboxamide derivatives, their preparation and their therapeutic use